PatentAuction.com lists patented inventions available for sale or licensing. Inventors can list their patented inventions (or patent pending) for sale. New inventions for sale are added on a daily basis !
Home    List your patent    My account     Help     Support us    

Cognitive Resilience for Dementia

[Category : - HEALTH]
[Viewed 11 times]

Supports early-stage dementia patients with memory-anchored, spaced recall sessions, emotional affirmation, and cognitive reinforcement. Supports early-stage dementia patients with memory-anchored, spaced recall sessions, emotional affirmation, and cognitive reinforcement.

Concept Note: ANSM for Early-Stage Dementia
Title:
Adaptive Neuro-Spaced Mastery (ANSM) for Memory Anchoring and Cognitive Resilience in Early-Stage Dementia
Summary:
The ANSM system, originally developed for educational recovery, is now adapted to support early-stage dementia patients. This application delivers memory-anchored, spaced recall sessions combined with emotional affirmation and cognitive reinforcement to slow memory decline and preserve dignity.
Core Features:
• Spaced Recall Cycles: Personalized intervals to practice and reinforce memory tasks (e.g., names, routines, faces)
• Emotional Affirmation: AI-guided encouragement after each session to reduce frustration and increase engagement
• Cognitive Reinforcement: Gradual difficulty adjustments based on patient performance, preserving pathways before they erode
Expected Outcomes:
• Slower cognitive deterioration
• Improved mood and self-confidence
• Reduced caregiver stress by enabling self-managed routines
2. Brief Patent Extension Description
Title:
Adaptive Neuro-Spaced Mastery (ANSM) for Neurocognitive Rehabilitation in Early-Stage Dementia
Abstract (for provisional filing or update):
This invention expands the ANSM framework beyond educational interventions into clinical neurocognitive rehabilitation. Specifically, the system provides early-stage dementia patients with personalized spaced-repetition activities combined with emotionally adaptive feedback, aiming to strengthen residual memory function, reinforce daily routines, and promote emotional well-being. The system includes (1) adaptive scheduling, (2) emotionally intelligent AI reinforcement, and (3) cognitive task tailoring, all integrated into an accessible digital platform. This extension preserves the core ANSM principles while applying them to the dementia care setting.
3. Summary for Clinical / Research Partnerships
Title:
Collaborative Opportunity: ANSM-Based Digital Intervention for Early Dementia Care
Overview:
We invite clinical, academic, and healthcare partners to join a pioneering project that applies Adaptive Neuro-Spaced Mastery (ANSM) technology to the care of early-stage dementia patients. By combining memory-anchored repetition with emotionally adaptive feedback, the system offers a novel, patient-centered approach to slowing cognitive decline and improving quality of life.
Partnership Benefits:
• Access to patented or patent-pending ANSM technology
• Collaborative design of dementia-specific modules
• Co-authorship in clinical validation studies
• Opportunity to co-develop commercial or nonprofit applications for global aging populations










Financial information

Commercialization and Partnership Overview for ANSM (Dementia Application)
1. What we are looking for:
We are seeking a strategic licensing partnership with royalties or milestone-based payments, or we are open to an outright sale of the invention. We also welcome co-development partnerships with healthcare or medtech firms to bring the ANSM system from its current provisional patent stage through validation, regulatory steps, and market launch.

2. Has the invention been previously sold or marketed?
No. The ANSM system has not been sold or marketed in the dementia or healthcare space. It is currently protected under provisional patent status and has been successfully applied in the educational sector (Game Changer™, AvaLearn™), but the dementia application is an entirely new and untapped market.

3. What is the market potential?
The global dementia care market is expected to reach $32 billion USD by 2030, with increasing demand for non-drug interventions, digital therapeutics, and cognitive support tools. As a first-of-its-kind emotionally adaptive system, ANSM has high market potential in:

Memory clinics and neurologist offices

Assisted living and home care services

Digital health and wellness platforms

Caregiver support programs
We estimate the commercial potential at $10M–$25M, with possible international licensing and public health partnerships.

4. Are there specific conditions for the sale?
Yes. If sold outright, we request:

Proper acknowledgment of BICQ Research Institute’s contribution in public-facing materials

Access to pilot or clinical data for academic publication

Good-faith discussion for potential collaboration on future social impact projects

If licensed, we seek:

Fair royalty rates or milestone payments

Participation in branding or technology acknowledgment

5. Are there other intellectual property pieces associated with the invention?
Yes. The ANSM invention is part of a provisional patent family that also includes:
Game Changer™ (educational recovery system)
AvaLearn™ (AI language and sign language tutor)
Veronica Version (ANSM + RMS + PQ) (for educational psychology)
While the dementia application itself is novel, it draws on this protected portfolio. Additional IP modules (e.g., motivational AI engines, cognitive reinforcement libraries) can be included in a licensing or purchase agreement.

















[ Home | List a patent | Manage your account | F.A.Q.|Terms of use | Contact us]

Copyright PatentAuction.com 2004-2017
Page created at 2025-05-07 0:09:22, Patent Auction Time.